A recommendation against PSA screening?1 I’ve been raising questions about the value of cancer screening for more than a decade,2 yet I’ve never recommended against it. But then again, I’ve never recommended for screening either. I guess that's why I’m not a member of the US Preventive Services Task Force.
As you can probably tell, I am a fence-sitter (and, by the end of this essay, maybe even a flip-flopper). While I believe that media campaigns, advocacy groups, and physicians have systematically exaggerated the benefits of cancer screening and have downplayed—or, worse, ignored—its harms, I also believe that both benefits and harms exist. And no matter how well researchers can quantify this trade-off (and there is much room for improvement here), the metrics are different: small changes in cancer-specific mortality vs a boatload of hassle factors and fear, some unnecessary treatment, some resulting complications, and even a very few deaths (that can be missed in the measurement of cancer-specific mortality3).
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.